MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets brain tumors from lung and breast cancer
Disease control Not yet recruitingThis Phase 2 trial tests a combination of two drugs, utidelone and bevacizumab, with or without a third drug called etoposide, in 56 patients with brain metastases from lung or breast cancer. The goal is to see if this treatment can shrink brain tumors and improve outcomes. Parti…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
One-Time immune boost for ARID1A-Mutant cancers?
Disease control Not yet recruitingThis early-phase trial is testing whether a single dose of two immunotherapy drugs (tremelimumab and durvalumab) can increase cancer-fighting immune cells inside tumors. It includes 34 people with untreated, non-metastatic stomach or esophageal cancers that have an ARID1A gene mu…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New imaging agent could spot hidden cancers
Diagnosis Not yet recruitingThis study tests a new radioactive imaging agent called 68Ga-SFB6-ZN01, which is designed to attach to a protein found on many cancer cells. 98 adults with confirmed or suspected cancer will receive a single injection of the agent and then have a PET/CT scan. The goal is to see i…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: Zhongnan Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New injection aims to fight Cancer-Related wasting
Symptom relief Not yet recruitingThis study tests a new drug called INB301 in people with cancer who are losing weight and muscle (cancer cachexia). The goal is to see if it is safe and can help patients gain or maintain weight. About 146 adults with solid tumors like lung, pancreatic, or colorectal cancer will …
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Yunnan Baiyao Group Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Healthy volunteers needed to test new version of cancer drug
Knowledge-focused Not yet recruitingThis early-stage study tests a new formulation of the cancer drug HRS-2189 in 28 healthy adults aged 18-45. The goal is to compare how the body absorbs the new versus the old tablet version and to check for safety. Participants will take a single dose of each formulation in rando…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC